Cyclin B1 (I120) polyclonal antibody 
Datasheet
COA
MSDS
SHIP
Product Name :
Cyclin B1 (I120) polyclonal antibody Background :
In eukaryotic cells, mitosis is initiated following the activation of a protein kinase known variously as maturation-promoting factor, M-phase specific histone kinase or M-phase kinase. This protein kinase is composed of a catalytic subunit (Cdc2), a regulatory subunit (cyclin B) and a low molecular weight subunit (p13 SUC1). The Cdc/cyclin enzyme is subject to multiple levels of control of which the regulation of the catalytic subunit by tyrosine phosphorylation is the best understood. Tyrosine phosphorylation inhibits the Cdc2/cyclin B enzyme and tyrosine dephosphorylation, occurring at the onset of mitosis, directly activates the pre-MPF complex. Evidence has estalished that B-type cyclins not only act on M-phase regulatory subunits of the Cdc2 protein kinase, but also activate the Cdc25A and Cdc25B endogenous tyrosine phosphatase, of which Cdc2 is the physiological substrate. The specificity of this effect is shown by the inability of either cyclin A or cyclin D1 to display any such stimulation of Cdc25A or Cdc25B. Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
Cyclin B1 (I120) polyclonal antibody detects endogenous levels of Cyclin B1 protein. Immunogen :
Synthetic peptide, corresponding to amino acids 90-140 of Human Cyclin B1. Conjugate :
Unconjugated Modification :
Unmodification
Cyclin B1 (I120) polyclonal antibody Background :
In eukaryotic cells, mitosis is initiated following the activation of a protein kinase known variously as maturation-promoting factor, M-phase specific histone kinase or M-phase kinase. This protein kinase is composed of a catalytic subunit (Cdc2), a regulatory subunit (cyclin B) and a low molecular weight subunit (p13 SUC1). The Cdc/cyclin enzyme is subject to multiple levels of control of which the regulation of the catalytic subunit by tyrosine phosphorylation is the best understood. Tyrosine phosphorylation inhibits the Cdc2/cyclin B enzyme and tyrosine dephosphorylation, occurring at the onset of mitosis, directly activates the pre-MPF complex. Evidence has estalished that B-type cyclins not only act on M-phase regulatory subunits of the Cdc2 protein kinase, but also activate the Cdc25A and Cdc25B endogenous tyrosine phosphatase, of which Cdc2 is the physiological substrate. The specificity of this effect is shown by the inability of either cyclin A or cyclin D1 to display any such stimulation of Cdc25A or Cdc25B. Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
Cyclin B1 (I120) polyclonal antibody detects endogenous levels of Cyclin B1 protein. Immunogen :
Synthetic peptide, corresponding to amino acids 90-140 of Human Cyclin B1. Conjugate :
Unconjugated Modification :
Unmodification
-
Western blot (WB) analysis of Cyclin B1 (I120) polyclonal antibody at 1:500 dilution Lane1:MCF-7whole cell lysate Lane2:sp2/0 cell lysate Lane3:H9C2 cell lysate -
Immunohistochemistry (IHC) analyzes of Cyclin B1 (I120) pAb in paraffin-embedded human breast carcinoma tissue.
Dihydroptychantol A, a macrocyclic bisbibenzyl derivative, induces autophagy and following apoptosis associated with p53 pathway in human osteosarcoma U2OS cells
PMCID: Pubmed No.:21185854
Temporal Dissection of K-rasG12D Mutant In Vitro and In Vivo Using a Regulatable K-rasG12D Mouse Allele
PMCID: Pubmed No.:22606359
Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line
PMCID: Pubmed No.:22619528
RhoC Regulates the Proliferation of Gastric Cancer Cells through Interaction with IQGAP1
PMCID: Pubmed No.:23145020
MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells
PMCID: Pubmed No.:23770000
LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells
PMCID: Pubmed No.:25645017
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT
PMCID: Pubmed No.:26025609
Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling
PMCID: Pubmed No.:26272184
Jumonji Domain Containing 5 (JMJD5) Associates with Spindle Microtubules and Is Required for Proper Mitosis
PMCID: Pubmed No.:26710852
PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells
PMCID: Pubmed No.:26860588
DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling
PMCID: Pubmed No.:25520862
Jumonji Domain Containing 5 (JMJD5) Associates with Spindle Microtubules and Is Required for Proper Mitosis
PMCID: Pubmed No.:26710852
PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells
PMCID: Pubmed No.:26860588
KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
PMCID: Pubmed No.:29520102
Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
PMCID: Pubmed No.:33990545
AIM2 promotes non‐small‐cell lung cancer cell growth through inflammasome‐dependent pathway
PMCID: Pubmed No.:30953357
WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics
PMCID: Pubmed No.:29989053
Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
PMCID: Pubmed No.:37295240
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.
Price/Size :
USD 368/1mg/vial
Tips:
For phospho antibody, we provide phospho peptide（0.5mg) and non-phospho peptide(0.5mg).Describe :
Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.Formula:
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.
Storage:
The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C.
Note :
This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.